313 related articles for article (PubMed ID: 31661141)
1. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.
Zhang L; Tian S; Pei M; Zhao M; Wang L; Jiang Y; Yang T; Zhao J; Song L; Yang X
Oncol Rep; 2019 Dec; 42(6):2655-2669. PubMed ID: 31661141
[TBL] [Abstract][Full Text] [Related]
2. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
3. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
4. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
[TBL] [Abstract][Full Text] [Related]
5. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
6. Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
Lai Y; He Z; Zhang A; Yan Z; Zhang X; Hu S; Wang N; He H
Genes Genomics; 2020 Jun; 42(6):691-698. PubMed ID: 32399935
[TBL] [Abstract][Full Text] [Related]
7. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
8. CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
Rosendo-Chalma P; Antonio-Vejar V; Bigoni-Ordóñez GD; Patiño-Morales CC; Cano-García A; García-Carrancá A
Int J Oncol; 2020 Jul; 57(1):301-313. PubMed ID: 32319591
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
[TBL] [Abstract][Full Text] [Related]
10. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
11. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
12. The role of Sp1 and EZH2 in the regulation of LMX1A in cervical cancer cells.
Lin WC; Yan MD; Yu PN; Li HJ; Kuo CC; Hsu CL; Lin YW
Biochim Biophys Acta; 2013 Dec; 1833(12):3206-3217. PubMed ID: 24018208
[TBL] [Abstract][Full Text] [Related]
13. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: a mechanistic study including molecular docking.
Saha SK; Khuda-Bukhsh AR
Eur J Pharmacol; 2014 Dec; 744():132-46. PubMed ID: 25448308
[TBL] [Abstract][Full Text] [Related]
14. MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2.
Sinha A; Ghosh A; Ghosh A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Sengupta S
Clin Epigenetics; 2024 Mar; 16(1):40. PubMed ID: 38461243
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.
Liu D; Zhou P; Zhang L; Wu G; Zheng Y; He F
Tumour Biol; 2011 Oct; 32(5):941-50. PubMed ID: 21674242
[TBL] [Abstract][Full Text] [Related]
16. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
17. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV-induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression.
Qu X; Li Y; Wang L; Yuan N; Ma M; Chen Y
J Cell Biochem; 2020 Oct; 121(10):4120-4129. PubMed ID: 31961005
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A.
Hu Y; Wu F; Liu Y; Zhao Q; Tang H
Clin Epigenetics; 2019 Dec; 11(1):186. PubMed ID: 31810492
[TBL] [Abstract][Full Text] [Related]
20. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
